Dalal RS, Mitri J, Goodrick H, Allegretti JR, et al. Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFalpha Agents for Ulcerative Colitis. J Clin Gastroenterol 2022 Aug 4. pii: 00004836-990000000-00040.
PMID: 36156528